Correlation Between Fortress Biotech and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Fortress Biotech and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortress Biotech and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fortress Biotech and Akero Therapeutics, you can compare the effects of market volatilities on Fortress Biotech and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortress Biotech with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortress Biotech and Akero Therapeutics.
Diversification Opportunities for Fortress Biotech and Akero Therapeutics
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Fortress and Akero is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Fortress Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortress Biotech are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Fortress Biotech i.e., Fortress Biotech and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Fortress Biotech and Akero Therapeutics
Given the investment horizon of 90 days Fortress Biotech is expected to under-perform the Akero Therapeutics. In addition to that, Fortress Biotech is 1.43 times more volatile than Akero Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about 0.01 per unit of volatility. If you would invest 4,949 in Akero Therapeutics on September 23, 2024 and sell it today you would lose (2,015) from holding Akero Therapeutics or give up 40.72% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Fortress Biotech vs. Akero Therapeutics
Performance |
Timeline |
Fortress Biotech |
Akero Therapeutics |
Fortress Biotech and Akero Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fortress Biotech and Akero Therapeutics
The main advantage of trading using opposite Fortress Biotech and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortress Biotech position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.Fortress Biotech vs. Fate Therapeutics | Fortress Biotech vs. Sana Biotechnology | Fortress Biotech vs. Caribou Biosciences | Fortress Biotech vs. Arcus Biosciences |
Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |